Table 5.12d

Adjusted Patient Survival, Living Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

		3 Months			1 Year			5 Years			10 Years
		(Tx 2005 - 2006)			(Tx 2005 - 2006)			(Tx 2001 - 2006)			(Tx 1996 - 2006)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	11,604	99.5%	0.1%	11,604	98.5%	0.1%	34,235	91.5%	0.2%	54,408	77.1%	0.4%
Transplant Center State	ALABAMA	313	99.2%	0.5%	313	99.0%	0.5%	901	90.6%	1.4%	1,398	75.7%	2.2%
	ARKANSAS	63	100.0%	0.0%	63	98.8%	1.2%	206	93.5%	1.8%	398	67.5%	4.1%
	ARIZONA	283	99.5%	0.4%	283	98.9%	0.5%	778	91.7%	1.3%	1,076	79.9%	2.9%
	CALIFORNIA	1,165	99.8%	0.1%	1,165	98.7%	0.3%	3,698	93.0%	0.6%	6,023	81.2%	0.9%
	COLORADO	203	99.6%	0.4%	203	98.4%	0.8%	486	91.0%	1.7%	774	74.4%	3.6%
	CONNECTICUT	88	100.0%	0.0%	88	98.0%	1.4%	318	95.1%	1.4%	619	78.2%	2.6%
	DELAWARE	0	-	-	0	-	-	12	+	+	16	+	+
	FLORIDA	405	99.8%	0.2%	405	98.7%	0.5%	1,119	91.5%	1.2%	1,751	75.2%	2.1%
	GEORGIA	203	99.1%	0.6%	203	97.3%	1.1%	640	92.6%	1.4%	987	78.2%	2.7%
	HAWAII	45	+	+	45	+	+	106	92.4%	3.4%	144	79.4%	5.8%
	IOWA	74	100.0%	0.0%	74	98.9%	1.1%	271	88.5%	2.6%	477	80.5%	2.7%
	ILLINOIS	647	99.4%	0.3%	647	98.2%	0.5%	1,758	92.7%	0.8%	2,602	76.3%	1.8%
	INDIANA	159	99.5%	0.5%	159	99.5%	0.5%	413	96.1%	1.3%	635	80.1%	3.0%
	KANSAS	40	+	+	40	+	+	130	92.0%	3.0%	220	78.2%	4.7%
	KENTUCKY	68	98.7%	1.2%	68	98.7%	1.2%	203	94.0%	2.0%	342	78.2%	4.7%
	LOUISIANA	123	100.0%	0.0%	123	99.2%	0.8%	417	89.3%	2.2%	668	71.5%	3.3%
	MASSACHUSETTS	352	99.3%	0.4%	352	99.3%	0.4%	1,031	93.2%	1.0%	1,767	82.0%	1.5%
	MARYLAND	326	99.5%	0.4%	326	97.7%	0.8%	980	88.2%	1.4%	1,794	74.5%	1.7%
	MAINE	41	+	+	41	+	+	147	89.4%	2.9%	226	84.6%	3.4%
	MICHIGAN	478	99.8%	0.2%	478	98.6%	0.5%	1,411	89.0%	1.1%	2,391	74.8%	1.5%
	MINNESOTA	644	99.4%	0.3%	644	98.1%	0.5%	1,912	91.1%	0.8%	2,911	77.3%	1.5%
	MISSOURI	236	99.6%	0.4%	236	98.9%	0.6%	654	93.3%	1.3%	1,151	78.7%	2.1%
	MISSISSIPPI	0	-	-	0	-	-	7	+	+	26	70.5%	11.2%
	NORTH CAROLINA	251	99.6%	0.3%	251	98.2%	0.8%	845	91.0%	1.3%	1,400	74.7%	2.3%
	NORTH DAKOTA	50	100.0%	0.0%	50	98.5%	1.5%	160	92.7%	2.2%	233	79.4%	5.0%
	NEBRASKA	108	99.2%	0.8%	108	99.2%	0.8%	258	93.1%	2.2%	380	80.3%	4.7%
	NEW HAMPSHIRE	31	+	+	31	+	+	85	97.3%	2.6%	135	89.1%	4.1%
	NEW JERSEY	342	99.3%	0.4%	342	98.8%	0.5%	995	93.5%	1.0%	1,407	75.7%	3.1%
	NEW MEXICO	33	+	+	33	+	+	132	92.2%	2.7%	215	83.3%	5.6%
	NEVADA	29	+	+	29	+	+	95	88.4%	4.0%	163	60.7%	8.8%
	NEW YORK	929	99.5%	0.2%	929	98.6%	0.4%	2,588	93.4%	0.7%	3,978	78.2%	1.4%
	OHIO	707	98.9%	0.3%	707	97.4%	0.5%	1,964	87.8%	1.0%	2,826	70.8%	1.9%
	OKLAHOMA	41	98.0%	2.0%	41	96.0%	2.7%	174	89.1%	2.7%	288	72.2%	5.0%
	OREGON	162	100.0%	0.0%	162	99.5%	0.5%	555	94.0%	1.3%	813	81.8%	2.9%
	PENNSYLVANIA	581	99.4%	0.3%	581	98.6%	0.5%	1,752	89.4%	1.0%	2,634	77.3%	1.5%
	PUERTO RICO	32	+	+	32	+	+	139	93.0%	2.8%	263	64.6%	6.1%
	RHODE ISLAND	54	96.7%	2.2%	54	96.7%	2.2%	183	88.9%	2.7%	269	77.8%	3.7%
	SOUTH CAROLINA	57	98.5%	1.4%	57	98.5%	1.4%	144	90.9%	2.7%	316	68.1%	4.6%
	SOUTH DAKOTA	39	98.0%	2.0%	39	93.9%	3.4%	94	89.5%	3.7%	116	90.1%	3.3%
	TENNESSEE	280	99.4%	0.4%	280	97.8%	0.8%	801	90.4%	1.4%	1,277	73.3%	2.5%
	TEXAS	647	99.3%	0.3%	647	98.6%	0.4%	1,869	91.3%	0.9%	3,041	76.6%	1.6%
	UTAH	148	100.0%	0.0%	148	99.4%	0.6%	439	94.4%	1.4%	740	82.0%	2.4%
	VIRGINIA	374	98.7%	0.5%	374	97.3%	0.8%	1,042	88.0%	1.4%	1,562	73.5%	2.5%
	VERMONT	23	97.1%	2.8%	23	94.0%	4.0%	46	96.4%	2.5%	83	85.6%	6.8%
	WASHINGTON	218	100.0%	0.0%	218	99.6%	0.4%	741	91.6%	1.2%	1,247	78.2%	2.1%
	WISCONSIN	309	99.5%	0.3%	309	98.5%	0.6%	904	92.5%	1.2%	1,501	79.3%	1.8%
	WEST VIRGINIA	30	+	+	30	+	+	101	80.4%	5.8%	182	65.8%	6.4%

Source: OPTN/SRTR Data as of May 1, 2008.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.